Back to Search Start Over

Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors.

Authors :
Vieira VA
Millar J
Adland E
Muenchhoff M
Roider J
Guash CF
Peluso D
Thomé B
Garcia-Guerrero MC
Puertas MC
Bamford A
Brander C
Carrington M
Martinez-Picado J
Frater J
Tudor-Williams G
Goulder P
Source :
AIDS (London, England) [AIDS] 2022 Jan 01; Vol. 36 (1), pp. 95-105.
Publication Year :
2022

Abstract

Background: Elite controllers are therapy-naive individuals living with HIV capable of spontaneous control of plasma viraemia for at least a year. Although viremic nonprogressors are more common in vertical HIV-infection than in adults' infection, elite control has been rarely characterized in the pediatric population.<br />Design: We analyzed the T-cell immunophenotype and the HIV-specific response by flow cytometry in four pediatric elite controllers (PECs) compared with age-matched nonprogressors (PNPs), progressors and HIV-exposed uninfected (HEUs) adolescents.<br />Results: PECs T-cell populations had lower immune activation and exhaustion levels when compared with progressors, reflected by a more sustained and preserved effector function. The HIV-specific T-cell responses among PECs were characterized by high-frequency Gag-specific CD4+ T-cell activity, and markedly more polyfunctional Gag-specific CD8+ activity, compared with PNPs and progressors. These findings were consistently observed even in the absence of protective HLA-I molecules such as HLA-B∗27/57/81.<br />Conclusion: Pediatric elite control is normally achieved after years of infection, and low immune activation in PNPs precedes the increasing ability of CD8+ T-cell responses to achieve immune control of viraemia over the course of childhood, whereas in adults, high immune activation in acute infection predicts subsequent CD8+ T-cell mediated immune control of viremia, and in adult elite controllers, low immune activation is therefore the consequence of the rapid CD8+ T-cell mediated immune control generated after acute infection. This distinct strategy adopted by PECs may help identify pathways that facilitate remission in posttreatment controllers, in whom protective HLA-I molecules are not the main factor.<br /> (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.)

Details

Language :
English
ISSN :
1473-5571
Volume :
36
Issue :
1
Database :
MEDLINE
Journal :
AIDS (London, England)
Publication Type :
Academic Journal
Accession number :
34581306
Full Text :
https://doi.org/10.1097/QAD.0000000000003078